Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 2, 2025

Datavault AI Keluarkan Maklum Balas Rasmi Terhadap Laporan Pendek Berniat Jahat oleh Wolfpack Research; Syarikat Tegaskan Kekuatan Harta Intelek, Kepimpinan dan Arah Strategik

View original at globenewswire.com
Datavault AI Keluarkan Maklum Balas Rasmi Terhadap Laporan Pendek Berniat Jahat oleh Wolfpack Research; Syarikat Tegaskan Kekuatan Harta Intelek, Kepimpinan dan Arah Strategik PHILADELPHIA, Nov…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Abusive, fraudulent, and manipulative practices mislead the market, sow distrust, and harm shareholders

    80% confidence
  • Our strategy is based on intellectual property and execution, not speculation

    80% confidence
  • It is clear that these parties are profiting financially through the dissemination of false information

    80% confidence
  • Wolfpack Research report contains false, misleading, and defamatory statements intended to manipulate Datavault AI stock for financial gain through short selling activities

    80% confidence
  • Mr. Bradley is committed to acting in the best interests of Company shareholders and that is the primary reason legal action is being taken against the authors of the defamatory report

    80% confidence
  • The appropriate place for those disseminating and supporting 'short and distort' content is in the defendant's chair in court and that is exactly where the Company intends to place Wolfpack Research

    80% confidence
  • The technology we have developed has created value across various industries — from digital identity and healthcare to acoustic data to real-world asset tokenization. This foundation is unshaken

    80% confidence
  • Datavault AI intends to file legal action to hold Wolfpack Research accountable for malicious conduct and protect shareholder rights

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Datavault AI Keluarkan Maklum Balas Rasmi Terhadap Laporan Pendek Berniat Jahat oleh Wolfpack Research; Syarikat Tegaskan Kekuatan Harta Intelek, Kepimpinan dan Arah Strategik — Source | Via News | ViaNews Market